Pharmaceutical Contract Manufacturing Organisation (CMO)
Xavier Castelli, CEO
Sébastien Aguettant, Managing Director
MBO, spin-off (Laboratoire Aguettant), build-up
Activa Capital's role
Tours, Brétigny-sur-Orge, Evreux, Lille - 550 employees
Reinforce Delpharm's leading position in the French market through the acquisition of other CMOs in France and Europe.
In May 2006, Delpharm acquired from Schering its French manufacturing plant based in Lille. In 2005, this unit realised sales of €36m.
In June 2007, Activa Capital exited Delpharm. The management team has acquired a majority stake in Delpharm.